This inventor holds 1 USPTO granted patent. Top assignees: Tessa Therapeutics Pte. Ltd, The University of North Carolina at Chapel Hill. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 1,331 
Years Active: 2026
Title: Ivan David Horak: Innovator in Cancer Treatment
Introduction
Ivan David Horak is a notable inventor based in Singapore, recognized for his contributions to the field of cancer treatment. He has developed innovative solutions aimed at addressing CD30-positive cancer, showcasing his commitment to advancing medical science.
Latest Patents
Horak holds a patent for the "Treatment of CD30-Positive Cancer." This patent represents a significant step forward in the fight against this specific type of cancer, highlighting his expertise and dedication to improving patient outcomes.
Career Highlights
Throughout his career, Ivan David Horak has worked with esteemed organizations, including Tessa Therapeutics Pte. Ltd and The University of North Carolina at Chapel Hill. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Horak has collaborated with Aung Myo, further enhancing his work in cancer treatment. Their partnership exemplifies the importance of teamwork in the pursuit of innovative medical solutions.
Conclusion
Ivan David Horak's work in cancer treatment, particularly with his patent for CD30-positive cancer, underscores his role as a significant innovator in the medical field. His collaborations and career achievements reflect his dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile